Displaying 1 - 20 of 10065
FTC Warns Companies Making Questionable ‘Made in the USA’ Claims
FTC v. Hopper (USA), Inc.
The companies that operate the Hopper travel apps have agreed to pay $35 million and will be prohibited from deceiving consumers about fees to settle the Federal Trade Commission’s allegations that they unfairly charged consumers hidden fees and misrepresented the total prices consumers would pay and the benefits of the companies’ VIP Support and Price Freeze services.
The FTC’s complaint alleges that despite its “no hidden fees” promises, Canadian company Hopper Inc. and its Massachusetts-based subsidiary Hopper (USA) Inc., unfairly charged users without their consent for “Tip” and VIP Support fees that the company claimed were optional yet were hidden and pre-selected for consumers.
Publishing.com, In the Matter of
Publishing.com LLC and its two principals will pay $1.5 million and be required to substantiate earnings claims in the future to settle Federal Trade Commission charges that the company and its operators misled consumers about how much money they were likely to earn using their products.
Travel App Hopper to Pay $35 Million to Settle FTC Allegations It Charged Fees Without Consent and Deceived Users About Fees and Benefits of Some Products
FTC Approves Final Order Against Publishing.com, Settling Allegations It Misled Consumers
FTC Seeks Public Comment on Policy Statement Addressing AI Accuracy
Amazon.com, Inc., U.S. v.
Amazon will pay $2.25 million in civil penalties to settle FTC allegations that the online retail giant knowingly violated the 609(e) of the Fair Credit Reporting Act by refusing to provide transaction records to consumers whose personal information was used by identity thieves to commit fraud.
FTC Requires Amazon to Pay $2.25 Million to Resolve Charges It Knowingly Violated the Fair Credit Reporting Act
FTC v Kochava, Inc.
The FTC will prohibit data broker Kochava and its subsidiary from selling, sharing or disclosing sensitive location data without consumer consent to settle allegations the companies sold location data from hundreds of millions of mobile devices that could be used to trace the movements of individuals.
Growthmind/Wisey
At the Federal Trade Commission’s request, a federal court has temporarily halted a sprawling enterprise of deceptive subscription schemes—comprised of 15 corporations and eight individuals—from continuing to deceive consumers with hidden costs and recurring charges, while failing to provide simple mechanisms to cancel subscriptions.
FTC Sues to Stop Sprawling Enterprise Operating Unlawful Subscription Schemes
WPATH, FTC v.
The Federal Trade Commission, along with Alaska, Iowa, Nebraska and Texas, today filed a lawsuit against the World Professional Association for Transgender Health (WPATH), alleging the organization has provided the means for medical providers to make false and unsubstantiated claims to parents in order to sell pediatric medical transition services.
FTC, States Sue World Professional Association for Transgender Health Over Deceptive Claims Regarding the Treatment of Children
PEP VIII/Cantaloupe, In the Matter of
FTC Data Show People Reported Losing $3.5 Billion to Imposter Scams in 2025
FTC Files Contempt Motion Against Amare Global and Three Individuals Over Unsubstantiated Health Claims
Amare Global Holdings, FTC v.
The FTC sued multilevel marketer Amare Global Holdings Inc. and three of its principals for misrepresenting to parents and other consumers that its dietary supplements marketed for children and adults could treat or cure health conditions such as depression, anxiety and ADHD, and for misleading its seller recruits about their potential earnings as “brand partners.”
The Federal Trade Commission has asked a federal court to hold in contempt dietary supplement provider Amare Global Holdings as well as its former Chief Science Officer Shawn Talbott and two other individuals over allegations they violated an FTC order in the Window Rock case that banned Talbott and those who work with him from making false, deceptive or unsubstantiated health claims.